Quinolinic acid

Research use only, not for human use.

Quinolinic acid is an endogenous N-methyl-D-aspartate (NMDA) receptor agonist synthesized from L-tryptophan via the kynurenine pathway.

Quinolinic acid is an endogenous N-methyl-D-aspartate (NMDA) receptor agonist synthesized from L-tryptophan via the kynurenine pathway.

Quinolinic acid (0-50 mM; 24 hours) decreases the percentage of survival cells ranging from 100±0.01% at 5 mM to 45.23±0.01% at 50 mM in N18D3 cells. Cell Viability Assay Cell Line:N18D3 cells, hybrid neuronal cell line obtained by fusion of dorsal root ganglions isolated from 4-week-old Balb/C mouse with the mouse neuroblastoma N18TG2 cells Concentration:0, 10, 20, 30, 40, 50 mM Incubation Time:24 hoursResult:There was a corresponding decrease in the percentage of survival cells ranging from 100±0.01% at 5 mM to 45.23±0.01% at 50 mM.

——

——

Others

Other Targets

NMDA receptor

——

——

89-00-9

173.17

C10H7NO2

>98% (HPLC)

DMSO : 33.33 mg/mL 199.44 mM

OC(=O)c1cccnc1C(O)=O

——

(-20℃)

With Ice Pack

≥ 2 years